Bristol-Myers Squibb Company
BMY
$47.85
$1.302.79%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 177.19% | 188.14% | -211.50% | -187.60% | -182.14% |
| Total Depreciation and Amortization | -35.33% | -18.00% | -1.99% | 4.17% | 0.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.28% | -80.12% | 780.84% | 711.77% | 533.44% |
| Change in Net Operating Assets | 209.74% | -253.65% | 142.32% | 112.05% | 69.38% |
| Cash from Operations | 12.27% | 4.27% | 9.60% | 16.18% | 19.52% |
| Capital Expenditure | -8.62% | -0.74% | -3.23% | 2.04% | -7.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 96.61% | 91.27% | -1,766.64% | -3,075.43% | -513.71% |
| Divestitures | 10.21% | 19.28% | 20.90% | -26.98% | -26.16% |
| Other Investing Activities | -188.65% | 1.12% | 174.82% | -94.35% | -107.02% |
| Cash from Investing | 93.89% | 89.71% | -830.37% | -8,623.48% | -1,512.86% |
| Total Debt Issued | -99.43% | -98.11% | 258.45% | 5,481.57% | 6,574.59% |
| Total Debt Repaid | 35.38% | -148.96% | -46.86% | -325.39% | -12.48% |
| Issuance of Common Stock | -- | -- | -- | 1,150.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 3.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.64% | -3.13% | -2.51% | -1.61% | -1.88% |
| Other Financing Activities | -48.44% | -2,140.00% | -- | -148.60% | -133.16% |
| Cash from Financing | -229.48% | -226.96% | 154.45% | 156.76% | 149.40% |
| Foreign Exchange rate Adjustments | 559.26% | -100.00% | -404.44% | 41.94% | -179.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 396.62% | 438.81% | -153.42% | 183.55% | 16.02% |